Company Filing History:
Years Active: 2007-2017
Title: Innovations and Contributions of Robert A. Mate
Introduction
Robert A. Mate is a distinguished inventor based in Waterbury, Connecticut, known for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he has made remarkable advancements in the treatment of various central nervous system disorders.
Latest Patents
Among his latest patents, one notable invention is related to tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands. This patent discloses compounds of formula I, including their salts, as well as compositions and methods of using these compounds. The compounds serve as ligands for the nicotinic α7 receptor and may be beneficial in treating various disorders of the central nervous system, particularly affective and neurodegenerative disorders. Another significant patent involves α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors. This patent presents a series of novel α-(N-sulfonamido)acetamide compounds that inhibit β-amyloid peptide production, proving useful in the treatment of Alzheimer's Disease and other conditions influenced by anti-amyloid activity.
Career Highlights
Robert A. Mate is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work has been pivotal in developing new therapeutic options for patients suffering from debilitating conditions.
Collaborations
Throughout his career, Robert has collaborated with notable colleagues, including John E. Macor and Ivar M. McDonald. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Robert A. Mate's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.